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1. Introduction 
Phosphoglycerate kinase (PGK, ATP3-phospho-D- 
glycerate-1 -phospho-transferase, EC 2.7.2.3) is the 
glycolytic enzyme that catalyses the fol$wing reac- 
tion: 1,3diphosphoglycerate t ADP !!!& 3-phospho- 
glycerate + ATP [ 11. The enzyme is active as a mono- 
mer with a relative molecular mass J4, of 44 000 [ 2,3], 
Treatment of PGK with the arginine-modifying 
reagent, phenylglyoxal leads to loss of activity [4&6]; 
the substrate, 3-phosphoglycerate can protect against 
inactivation. 
We report here that PGK purified by affinity elu- 
tion is not inactivated by phenylglyoxal, and it is 
shown that this is due to the presence of tightly bound 
3-phosphoglycerate. 
2. Materials and methods 
2 .l . Purijkation and characterization of PGK 
PGK was purified from dried baker’s yeast (Saccha- 
romyces cerevisiae), obtained from the Distillers Co., 
by the method in [7-91. The procedure involves 
extraction, ammonium sulphate precipitation and 
affinity elution from CM-cellulose by 3-phosphogly- 
cerate. An additional gel filtration step using Sephadex 
G-200 was sometimes required. The PGK was charac- 
terized by enzymic assay, SDS-polyacrylamide gel 
electrophoresis, and amino acid analysis, and was 
shown to have spec. act. 2650 U/mg and to be of high 
purity. 
2.2. Assay of enzymic activity 
The activity of PGK was assayed by coupling the 
reaction to that catalysed by glyceraldehyde-3-phos- 
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phate dehydrogenase, and monitoring the oxidation 
of NADH [ 81. Protein was estimated as in [ lo], and 
spectrophotometricaly, using A:*:: = 5 .O at 280 nm 
1111. 
2 3. Modification of arginine residues 
Reactive arginine residues were modified by the 
argininespecific reagent phenylglyoxal according to 
[4].PGK(2mg/ml,45/~M)wasincubatedwith2.0mM 
phenylglyoxal, the conditions shown [4,6] to lead to 
95% inactivation in the absence of 3-phosphoglycerate, 
but only 5% inactivation in the presence of 20 mM 
3-phosphoglycerate. 
3. Results and discussion 
PGK purified by affinity elution was resistant to 
inactivation by 2.0 mM phenylglyoxal (fig.1). Gel fil- 
tration of PGK on Sephadex G-200 and/or exhaustive 
dialysis did not alter its resistance to phenylglyoxal 
inactivation. It seemed possible that the resistance to 
inactivation might result from tightly-bound 3-phos- 
phoglycerate, and three procedures were used to 
examine this possibility. 
(i) Guanidinium chloride: The PGK was treated 
with 2.0 M guanidinium chloride followed by dialysis 
against water at 4”C, conditions known to cause the 
reversible unfolding of PGK [ 121. This procedure was 
repeated 3 times. 
(ii) Sodium sulphate: The PGK was suspended in 
0.5 M sodium sulphate, dialysed against 0.5 M sodium 
sulphate and then dialysed against water. The proce- 
dure was repeated 3 times. 
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Fig.1. Phenylglyoxal inactivation of PGK. The susceptibility 
of different PGK preparations to inactivation by 2.0 mM 
phenylglyoxal was measured. (0) PGK purified by affinity 
elution; PGK after the following treatments; (0) 2.0 M guan- 
idinium chloride; (m) 0.5 M sodium sulphate; (0) glyceralde- 
hyde-3phosphate dehydrogenase, ATP and NADH. Details of 
these treatments are given in section 2. 
(iii) Glyceraldehyde-3-phosphate dehydrogenase 
[GAPDH (Sigma) from yeast, crystalline suspension 
in 3 .O M ammonium sulphate solution]: The PGK 
(10 nmol) was incubated with a 5-fold molar excess 
of NADH, ATP (50 nmol) and 0.36 pmol GAPDH for 
45 min at 37”C, and then dialysed against water. (The 
GAPDHmay subsequently be removed by gel filtration 
if desired.) 
containing tightly bound 3-phosphoglycerate ven 
after gel filtration or dialysis. The removal of the 3- 
phosphoglycerate by GAPDH treatment was examined 
in more detail to quantify the amount of bound 3- 
phosphoglycerate. The rate and extent of NADH oxi- 
dation due to the 3-phosphoglycerate bound to PGK 
is shown in fig.3. The conditions of assay using an 
excess of GAPDH were chosen to ensure that the 
GAPDHreaction was not rate-limiting. A semi-log plot 
of these data gives a straight line, indicating that the 
reaction is first order with respect to 3-phosphogly- 
cerate concentration. The amount of 3-phosphogly- 
cerate bound to PGK was calculated to be 1 .l mol/ 
mol PGK (fig.3). 
PGK is the object of much interest, being a mom 
merit enzyme for which rotation about the bond 
The susceptibility to phenylglyoxal inactivation of 
PGK treated by these 3 procedures is shown in fig.1. 
It is apparent that all 3 procedures have rendered 
PGK sensitive to phenylglyoxal treatment, and that 
the GAPDH procedure allowed the most extensive 
phenylglyoxal modification. 
As a control, the effect of the 3 treatments on the 
specific activity of PGK was measured (table 1). The 
GAPDH treatment caused virtually no loss of specific 
activity, whereas the repeated denaturation of PGK in 
guanidinium chloride led to -20% inactivation. 
The extent of modification of arginine residues by 1 2 3 
phenylglyoxal was correlated with loss of activity by Moles Arginine Modified / Mole PGK 
measuring the loss of arginine detected by amino acid 
analysis (fig.2). It can be seen that modification of 
Fig.2. Extent of argininemodification. The number of arginine 
between 2 and 3 arginine residues occurs with complete 
residues modified/m01 PGK was determined by measuring the 
loss of arginine by ammo acid analysis. Extrapolation to zero 
inactivation. activity indicates that 2.7 mol arginine/mol PGK were modi- 
These results are consistent with purified PGK fied . 
Table 1 
Recovery of PGK activity after treatment 
Treatment Initial Spec. act. % Decrease 
spec. act. after treatment spec. act. 
(units/mg) (units/mg) 
(i) Guanidinium 
chloride 660 540 18 
(ii) Sodium 
sulphate 660 640 3 
(iii) GAPDH 660 650 2 
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Details of the treatment procedures are given in section 2 
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Fig.3. Rate of NADH oxidation by PGK. Purified PGK (0) 
(0.183 mM) was incubated with ATP (4 mM), NADH (2 mM) 
and GAPDH (5 PM). The control values (0) were from PGK 
that had already been treated with ATP, NADH and GAPDH 
to remove the 3phosphoglycerate, and to which a second 
addition of NADH was made. The decrease in A 34,, was 1.3 
so the concentration of NADH oxidised was 0.209 mM 
(ES40 = 6.2 X 10’ M cm-‘). There were therefore 1.1 mol 
3-phosphoglycerate/mol PGK. 
linking its two domains is proposed as part of the cat- 
alytic mechanism [ 13 ,141. The exact location of the 
3-phosphoglycerate binding site is however based on 
circumstantial rather than direct evidence from X-ray 
crystallographic studies [ 13 ,15-l 71 so that further 
chemical modification studies may be useful. Avariety 
of ligands have been shown to have marked effects on 
the flow properties of the enzyme [ 18],and substrates 
bring about substantial changes in its stability (B. A., 
in preparation). It is clearly important for these and 
for kinetic studies that a pure enzyme free from bound 
ligands is available. The enzyme purification step 
described here fulfills this requirement. 
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